Effects of non-steroidal anti-inflammatory drugs on the luminol and lucigenin amplified chemiluminescence of human neutrophils

European Journal of Pharmacology

Volumn 352, Issue 2-3, 1998, Pages 299-305

  Parij, Nathalie ^a   Nagy, Anne Marie ^a   Fondu, Pierre ^a   Nève, Jean ^a  

^a NONE

Author keywords

Chemiluminescence; Free radical; Lucigenin; Luminol; NSAID (non steroidal anti inflammatory drug; Opsonised yeast; Polymorphonuclear neutrophil

Indexed keywords

ACEMETACIN; ACETYLSALICYLIC ACID; DICLOFENAC; FLUFENAMIC ACID; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; LUCIGENIN; LUMINOL; NAPROXEN; NIFLUMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; REACTIVE OXYGEN METABOLITE; TENOXICAM; TOLMETIN;

ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL;

ACRIDINES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMILUMINESCENT MEASUREMENTS; HUMANS; LUMINOL; NEUTROPHILS;

EID: 0031879262     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00370-7     Document Type: Article

References (31)

1. Aruoma, O.I., Haliwell, B., 1988. The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugs. Xenobiotica 18, 459-470.
2. Bender, J.G., Van Epps, D.E., 1983. Analysis of the bimodal chemiluminescence pattern stimulated in human neutrophils by chemotactic factors. Infect. Immun. 41, 1062-1070.
3. Black, H.S., 1989. Role of reactive oxygen species in inflammatory process. In: Hensbyand, C., Lowe, N.J. (Eds.), Non-steroidal Anti-inflammatory Drugs: Pharmacology and the Skin, Vol. 2. Karger, Basel, pp. 1-20.
4. Boyum, A., 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21 (Suppl. 97), 77-89.
5. Brown, K.A., Perry, J.D., Black, C., Dumonde, D.C., 1988. Identification by cells electrophoresis of a subpopulation of polymorphonuclear cells which is increased in patients with rheumatoid arthritis and certain other rheumatic disorders. Ann. Rheum. Dis. 47, 353-358.
6. Colli, S., Colombo, S., Tremoli, E., Stragliotto, E., Nicosia, S., 1991. Effects of tenoxicam on superoxide anion formation, β-glucuronidase release and fMLP binding in humans neutrophils: comparison with other NSAIDs. Pharmacol. Res. 23, 367-379.
7. Dahlgren, C., Stendhal, O., 1983. Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect. Immun. 39, 736-741.
8. Dahlgren, C., Aniansson, H., Magnusson, K.E., 1985. Pattern of formylmethionyl-leucyl-phenylalanine induced luminol and lucigenin-dependent chemiluminescence in human neutrophils. Infect. Immun. 47, 326-328.
9. Edwards, W., 1987. Luminol and lucigenin-dependent chemiluminescence of neutrophils: role of degranulation. J. Clin. Lab. Immunol. 22, 35-39.
10. Falck, P., 1986. Investigation of the chemiluminescence response of human neutrophils and mononuclear cells. Folia Biol. (Praha) 32, 103-115.
11. Gay, J.C., Lukens, J.N., English, D.K., 1984. Differential inhibition of neutrophil superoxide generation by non-steroidal anti-inflammatory drugs. Inflammation 8, 209-222.
12. Gay, J.C., English, D.K., Lukens, J.N., 1985. Stimulation of neutrophil oxidative metabolism by indomethacin. Agents Actions 16, 336-341.
13. Graf, P., Glatt, M., Brune, K., 1975. Acidic non-steroid anti-inflammatory drugs accumulating in inflamed tissue. Experientia 31, 951-953.
14. Gyllenhammar, H., 1987. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J. Immunol. Methods 97, 209-213.
15. Haliwell, B., Guteridge, J.M.C., Blake, D., 1985. Metal ions and oxygen radical reactions in human inflammatory joint disease. Philos. Trans. R. Soc. London, Ser. B 311, 659-671.
16. 2 in the chemiluminescence of luminol. Photochem. Photobiol. 18, 451-455.
17. Horan, T.D., Noujaim, A.A., Mc Pherson, T.A., 1983. Effect of indomethacin on human neutrophil chemiluminescence and microbicidal activity. Immunopharmacology 6, 97-106.
18. Mazzulo, G., Calabria, A.A., Lalumera, M., Fioravanti, A., Bacarelli, M.R., Pucci, G., Rinieri, A., 1985. Effeti in vitro dei farmaci antiflogistici non-steroidei sulla produzione dei radicali dell'ossigeno valutata mediante la riposta chemiluminescente dei leucociti polimorfonucleati. Boll. Soc. Ital. Biol. Sper. LXI, 1193-1198.
19. Misra, H.P., Squatrito, P.M., 1982. The role of superoxide anion in peroxidase catalysed chemiluminescence of luminol. Arch. Biochem. Biophys. 215, 59-65.
20. Muller-Peddinghaus, R., 1984. In vitro determination of phagocyte activity by luminol and lucigenin-amplified chemiluminescence. Int. J. Immunopharmacol. 6, 455-466.
21. Mustofa, M., Suryawati, S., Dwiprahasto, I., Santoso, B., 1991. The relative bioavailability of diclofenac with respect to time of administration. Br. J. Clin. Pharmacol. 32, 246-247.
22. Netter, P., Bannwarth, B., Royer-Morrot, M.J., 1989. Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid. Clin. Pharmacokinet. 17, 145-162.
23. Parij, N., Neve, J., 1996. Non-steroidal anti-inflammatory drugs interact with horseradish peroxidase in an in vitro assay system for hydrogen peroxide scavenging. Eur. J. Pharmacol. 311, 259-264.
24. Parij, N., Nagy, A.M., Nève, J., 1995. Non-linear competition plots in the deoxyribose assay for determination of rate constants for reaction of some non-steroidal anti-inflammatory drugs with hydroxyl radical. Free Radic. Res. 23, 571-579.
25. Pekoe, G., Van Dycke, K., Peden, D., English, D., 1981. Effects of non-steroidal anti-inflammatory drugs on chemiluminescence from isolated human myeloperoxidase. Am. Soc. Photobiol. 9, 183.
26. Pekoe, G., Van Dycke, K., Peden, D., Mengoli, H., English, D., 1982. Anti-oxidant theory of non-steroidal anti-inflammatory drugs based upon the inhibition of luminol-enhanced chemiluminescence from the myeloperoxidase reaction. Agents Actions 12, 371-376.
27. Urquhart, E., 1991. A comparison of synovial fluid concentrations of non-steroidal anti-inflammatory drugs with their in vitro activity. Agents Actions 32, 261-265.
28. Vapaatalo, H., 1986. Free radicals and anti-inflammatory drugs. Med. Biol. 64, 1-7.
29. Wasil, M., Halliwel, B., Moorhouse, C.P., Duncan, C., Hutchinson, S., Baum, H., 1987. Biologically-significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by some anti-inflammatory drugs. Biochem. Pharmacol. 36, 3847-3850.
30. Weiss, S.J., 1989. Tissue destruction by neutrophils. New Engl. J. Med. 320, 365-376.
31. Weiss, S.J., Lobuglio, A.F., 1984. Phagocyte-generated oxygen metabolites and cellular injury. In: Rubin, E., Damjanov, I. (Eds.), Advance in the Biology of Disease, Vol. 1. Williams/Wilkins, London, pp. 2-15.